logo

Empowering Innovation and Growth through Strategic Partnerships

   

Added on  2019-09-25

14 Pages3463 Words254 Views
Leadership Management
 | 
 | 
 | 
Biocon India GroupStrategic Management AnalysisStudent Name: Student ID: Course Name: Course ID:Faculty Name: University Name:
Empowering Innovation and Growth through Strategic Partnerships_1

1Table of ContentsIntroduction................................................................................................................................21.2 Stakeholder Analysis............................................................................................................2Employees..............................................................................................................................3Customers...............................................................................................................................3Suppliers.................................................................................................................................4Creditors.................................................................................................................................4Investors.................................................................................................................................4Government............................................................................................................................5Community.............................................................................................................................5Stakeholder Mapping.............................................................................................................52.2 Industry Analysis.................................................................................................................6Power of Suppliers.................................................................................................................6Power of Buyers.....................................................................................................................7Barriers to Entry.....................................................................................................................7Threat of Substitutes..............................................................................................................8Competitive Rivalry...............................................................................................................83.1 Strategic Capabilities...........................................................................................................84 Business and Corporate Strategies........................................................................................10Conclusion................................................................................................................................11References................................................................................................................................12
Empowering Innovation and Growth through Strategic Partnerships_2

2IntroductionBiocon is an innovation oriented biopharmaceutical company which is based out of Bangalore, India. Kiran Mazumdar-Shaw is the chairman and managing director of the company. The started its business with enzyme business in the year 1978 and now it expanded its wing into the pharmaceutical industry (Suryanarayan, 2003). The pharmaceutical products of the company are sold in various markets such as India, United States, and various European countries. There are multiple subsidiaries of the company and key ones are Syngene International Pvt Ltd, and Clinigene (Kalegaonkar et al, 2008). The company has achieved appreciable growth since its inception and is looking forward to gain the benefit out of the changing market place and need. This paper is concerned with analysing the various strategic aspects of the company to understand the opportunities and challenges that lies ahead. The second chapter focuses on the stakeholders’ analysis of the company. The third chapter will focus on analysing the pharmaceutical industry in which the company is active at present. The fourth chapter analyses the resources and capabilities of the company using the VRIO/VRIN criteria. The fifth chapter suggests applicable and possible business and corporate strategies for the company. The final chapter gives conclusive remarks on the overall study of the company’s strategies and possible growth. 1.2 Stakeholder AnalysisStakeholders refer to the individuals or entities that are associated with the company in one way or the other and will be impacted by the rise and fall of the company (Donaldson & Preston, 1995). There are various stakeholders of the Biocon India Group that has been discussed in the sub-sections of this chapter. As the company is into the field of
Empowering Innovation and Growth through Strategic Partnerships_3

3pharmaceutical, therefore it becomes an important aspect that the stakeholder analysis is considered carefully. There are various entities who will be impacted by the actions of the company.EmployeesThe employees of the company are the most important stakeholder. These stakeholders contribute directly to the growth of the company and get impacted by the decisions of the company. The employees of Biocon have been given enough freedom and flexibility to conduct their everyday activites. The company has ensured that the working environment of Biocon stay conducive for the individuals with the presence of all kinds of facilities. Moreover, the provision to help grow those who are meritorious has instilled the culture of growth. The employees strive for more and learn more. The interesting thing that has been identified is that the company do not expect any ideas or major contribution from the employees for at-least two years from their joining as it considers that usually it takes two years to open up in Biocon.CustomersThe customers of Biocon are from wider geography, ranging from US, Europe, and India. The customers are also directly impacted by the decisions made by the company. The customers of the company are either entity from the distribution channel like distributors, retailers, end consumers, government (for free distribution purposes), private hospitals, and others. The customers are depended on the company’s decisions of price fluctuations and the support it provides to the customers. Biocon has kept its price moderate in all its market which has helped its customers stay with the company with good relations. The company should ensure that the decisions does not put any adverse impact on the customers as they arethe reason company exists in the market.
Empowering Innovation and Growth through Strategic Partnerships_4

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
International Business: Expanding Business Activities in Foreign Markets
|11
|2495
|48

Strategic Management of Marks and Spencer: A Comprehensive Analysis
|22
|5440
|157

Strategic Management and Sustainability in Pharmaceutical Industry
|12
|3217
|197

Dialog Semiconductor PLC: A Comprehensive Analysis
|19
|3442
|455

Strategic Management in Hospitality: A Case Study of Whitbread Plc.
|12
|3805
|247

Understanding the Business Environment
|10
|2737
|80